Recruiting Phase 1 2025-524100-29-00

An Open-Label, Phase 1b, Multiple Ascending Dose Study of OM336 in Participants with Active Sjogren’s Disease or Idiopathic Inflammatory Myopathy

Phase 1 – testing safety in a small group of people

Conditions: Seropositive autoimmune disease: Sjogren’s disease or idiopathic inflammatory myopathy

Sponsor: Ouro Medicines Limited

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 65+ years, 18-64 years Gender: Female, Male Target enrollment: 8 participants

Czech Republic (1)

Status

Recruiting

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

21.04.2026

Registry ID

2025-524100-29-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.